Psilocybin study for meth addiction halted early – only 5 participants
NCT ID NCT05322954
First seen Jan 09, 2026 · Last updated Jun 13, 2026 · Updated 27 times
Summary
This study looked at whether psilocybin, a psychedelic drug, is safe and practical to use alongside behavioral support for people with methamphetamine use disorder. Only 5 participants were enrolled before the study was stopped early. The main goal was to track serious side effects and see if people would stick with the treatment plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.